KAIROS PHARMA LTD (KAPA) Stock Earnings & Estimates
NYSEARCA:KAPA - US48301N1046 - Common Stock
1.18 USD
+0.01 (+0.85%)
1.17 USD
-0.01 (-0.85%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||||
| EBITDA YoY % growth | -1.845M | -411K 77.72% | -1.554M -278.10% | -2.183M -40.48% | N/A -124.28% | N/A -43.75% | N/A -113.04% | |
| EBIT YoY % growth | -1.943M | -571K 70.61% | -1.714M -200.18% | -2.343M -36.70% | N/A -30.60% | N/A -300.00% | N/A -66.67% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A -41.67% | N/A -50.59% | N/A -35.16% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.06 -175.00% | -0.06 38.80% | -0.06 23.50% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | -1.122M -690.14% | -1.224M -365.40% | -1.734M -34.84% |
| EBIT Q2Q % growth | -691.05K -211.28% | -749.7K -95.74% | -809.88K 43.99% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.08 -161.44% | -0.05 | -0.03 | -56.86% |
| Q4 2024 Q2Q % growth | -0.08 | -0.04 | -0.04 | -124.09% |
| Q3 2024 Q2Q % growth | -0.10 | -0.02 | -0.08 | -390.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |